Our recent work has uncovered a whole network of oncogenes (ONC) and tumor suppressors (TS) promoting NASH and HCC (e.g., S100A11), thus pointing to the importance of mutation-independent alterations in the development of HCC [4]. This evidence concerns the gene S100A11 and hepatocellular carcinoma.